GI
TERN

GAMMA Investing’s Terns Pharmaceuticals TERN Stock Holding History

GAMMA Investing’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-926
Closed -$48.8K – 4226
2026
Q1 		$48.8K Buy
926
+55
+6% +$2.26K ﹤0.01% 2196
2025
Q4 		$35.2K Buy
871
+770
+762% +$17.8K ﹤0.01% 2298
2025
Q3 		$759 Buy
+101
New +$645 ﹤0.01% 3656
2025
Q1 		– Sell
-418
Closed -$2.32K – 3881
2024
Q4 		$2.32K Sell
418
-165
-28% -$1.12K ﹤0.01% 3178
2024
Q3 		$4.86K Buy
583
+170
+41% +$1.4K ﹤0.01% 2756
2024
Q2 		$2.81K Sell
413
-614
-60% -$3.72K ﹤0.01% 2773
2024
Q1 		$6.74K Buy
1,027
+883
+613% +$5.77K ﹤0.01% 2262
2023
Q4 		$746 Buy
+144
New +$761 ﹤0.01% 2876

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing's TERN Position: Q2 2026 in Review

GAMMA Investing sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 926 shares — an estimated $48.8K sold.

GAMMA Investing first reported a position in TERN in Q4 2023 and held it in 8 quarters. The position peaked at $48.8K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • GAMMA Investing reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • GAMMA Investing sold 926 Terns Pharmaceuticals shares in Q2 2026, an estimated $48.8K.
  • GAMMA Investing first reported a position in Terns Pharmaceuticals in Q4 2023 and held it in 8 quarters.
  • GAMMA Investing's Terns Pharmaceuticals position peaked at $48.8K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.